Claims against Trimedyne, Inc. and Convergent LaserTechnologies were settled in the Fall of 2010 through alternativedispute resolution. Claims against the remaining defendants,with the exception of Cardiogenesis, were voluntarily dismissed.-1-
United States District CourtDistrict of Massachusetts________________________________CARDIOFOCUS, INC.,Plaintiff,v.CARDIOGENESIS CORPORATION,Defendant.________________________________))))) Civil No.) 08-10285-NMG)))MEMORANDUM & ORDERGORTON, J.
This is a patent infringement action involving laser cathetersystems. Plaintiff CardioFocus, Inc. (“CardioFocus”) alleges thatdefendant Cardiogenesis Corporation (“Cardiogenesis”)manufactured, used, imported, sold, and offered for sale lasersthat infringed at least one of its two patents-at-issue: U.S.Patent Nos. 5,843,073 (“the ’073 patent”) and 6,547,780 (“the’780 patent”). Cardiogenesis is the only remaining defendant.
The ‘780 and ‘073 patents describe a system for transmittinglaser energy via an optical fiber for the purposes of tissueremoval and repair. The invention is based, in part, on the